Tags

Type your tag names separated by a space and hit enter

[Presence of prostate cancer, but absence of active treatment].

Abstract

Prostate cancer is the most common cancer in men. Because these tumours are usually detected by early diagnosis, prostate cancer is often limited to the prostate when diagnosed. Withholding active treatment, with active surveillance or watchful waiting are full options for men with this diagnosis. In active surveillance, men receive a structured follow-up with repeated determinations of the prostate-specific antigen (PSA) and prostate biopsies, often supported by MRI. When the tumour develops, active treatment can still be initiated. With this approach, the 10-year survival rate is high and a significant proportion of men remain untreated. With watchful waiting no structural monitoring takes place; instead one waits until the prostate cancer becomes symptomatic. This mainly concerns bone pain due to metastasis and obstruction of the urethra due to local growth. Explanation about these options is essential and GPs can play an important role in this.

Authors+Show Affiliations

,

Rijksuniversiteit Groningen, UMC Groningen, afd. Huisartsgeneeskunde en Ouderengeneeskunde. Contact: M.H. Blanker (m.h.blanker@umcg.nl).

Erasmus MC, afd. Urologie, Rotterdam.

Source

Pub Type(s)

English Abstract
Journal Article

Language

dut

PubMed ID

31187962

Citation

Blanker, Marco H., and Chris H. Bangma. "[Presence of Prostate Cancer, but Absence of Active Treatment]." Nederlands Tijdschrift Voor Geneeskunde, vol. 163, 2019.
Blanker MH, Bangma CH. [Presence of prostate cancer, but absence of active treatment]. Ned Tijdschr Geneeskd. 2019;163.
Blanker, M. H., & Bangma, C. H. (2019). [Presence of prostate cancer, but absence of active treatment]. Nederlands Tijdschrift Voor Geneeskunde, 163.
Blanker MH, Bangma CH. [Presence of Prostate Cancer, but Absence of Active Treatment]. Ned Tijdschr Geneeskd. 2019 May 31;163 PubMed PMID: 31187962.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Presence of prostate cancer, but absence of active treatment]. AU - Blanker,Marco H, AU - Bangma,Chris H, Y1 - 2019/05/31/ PY - 2019/6/13/entrez JF - Nederlands tijdschrift voor geneeskunde JO - Ned Tijdschr Geneeskd VL - 163 N2 - Prostate cancer is the most common cancer in men. Because these tumours are usually detected by early diagnosis, prostate cancer is often limited to the prostate when diagnosed. Withholding active treatment, with active surveillance or watchful waiting are full options for men with this diagnosis. In active surveillance, men receive a structured follow-up with repeated determinations of the prostate-specific antigen (PSA) and prostate biopsies, often supported by MRI. When the tumour develops, active treatment can still be initiated. With this approach, the 10-year survival rate is high and a significant proportion of men remain untreated. With watchful waiting no structural monitoring takes place; instead one waits until the prostate cancer becomes symptomatic. This mainly concerns bone pain due to metastasis and obstruction of the urethra due to local growth. Explanation about these options is essential and GPs can play an important role in this. SN - 1876-8784 UR - https://www.unboundmedicine.com/medline/citation/31187962/[Presence_of_prostate_cancer,_but_absence_of_active_treatment] DB - PRIME DP - Unbound Medicine ER -
Unbound Prime app for iOS iPhone iPadUnbound PubMed app for AndroidAlso Available:
Unbound MEDLINE
Unbound PubMed app for WindowsUnbound PubMed app for MAC OSX Yosemite Macbook Air pro